VAN BUREN TOWNSHIP, Mich. -- Visteon has received notification from the New York Stock Exchange (NYSE) that it has fallen below its continued listing standard, which requires a minimum average closing price of $1 per share over 30 consecutive trading days.
Visteon said it plans to cure the deficiency. The company has a period of six months to bring its average share price back above $1. Under NYSE rules, Visteon's common stock will continue to be listed on the NYSE during the cure period, subject to the company's compliance with other NYSE continued listing requirements.
